Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by wexworthon Nov 19, 2020 10:36pm
222 Views
Post# 31938537

RE:RE:RE:RE:RE:The CCP.

RE:RE:RE:RE:RE:The CCP.
there is a video of howie on youtube from the early days. he talks about licensing for royalty and upfront payments not selling products but i get your point. they thought people would bang down doors, only to see sglt2 and obagi develop during that time, but then last year the lightbulb went off and they realized geez we have to prove the prototype re: clinical trials. searching up new cosmetics from concept through formulation, marketing to shelf, quick time is 8-12 months, most take longer. easy google..for pharma clinical trials -10 yrs end to end. so mirror, i appreciate why you are frustrated and I have reached my limits too, but you nor any of us didn't hold out this long for no good reason, despite what we may think of management- we are at hour 23:57.
Bullboard Posts